ArticleThe Journal of biological chemistry2026

Siglec-1-targeting single domain antibodies block or enhance pathogen binding to dendritic cells.

Hendrik J Brink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.